These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14607450)

  • 1. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome.
    Morita H; Morita ST; Nagase S; Banba K; Nishii N; Tani Y; Watanabe A; Nakamura K; Kusano KF; Emori T; Matsubara H; Hina K; Kita T; Ohe T
    J Am Coll Cardiol; 2003 Nov; 42(9):1624-31. PubMed ID: 14607450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
    Tada T; Kusano KF; Nagase S; Banba K; Miura D; Nishii N; Watanabe A; Nakamura K; Morita H; Ohe T
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):56-61. PubMed ID: 17916151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
    Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y
    Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification for asymptomatic patients with Brugada syndrome.
    Morita H; Takenaka-Morita S; Fukushima-Kusano K; Kobayashi M; Nagase S; Kakishita M; Nakamura K; Emori T; Matsubara H; Ohe T
    Circ J; 2003 Apr; 67(4):312-6. PubMed ID: 12655161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient.
    Ohkubo K; Watanabe I; Okumura Y; Yamada T; Masaki R; Kofune T; Oshikawa N; Kasamaki Y; Saito S; Ozawa Y; Kanmatsuse K
    Pacing Clin Electrophysiol; 2003 Sep; 26(9):1900-3. PubMed ID: 12930508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias.
    Ogawa R; Kishi R; Mihara K; Takahashi H; Takagi A; Matsumoto N; Masuhara K; Nakazawa K; Miyake F; Kobayashi S; Echizen H
    J Clin Pharmacol; 2006 Jan; 46(1):59-68. PubMed ID: 16397285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlation in tissue models of Brugada syndrome simulating patients with sodium and calcium channelopathies.
    Morita H; Zipes DP; Morita ST; Wu J
    Heart Rhythm; 2010 Jun; 7(6):820-7. PubMed ID: 20206324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. J wave and ST segment elevation in the inferior leads: a latent type of variant Brugada syndrome?
    Sahara M; Sagara K; Yamashita T; Abe T; Kirigaya H; Nakada M; Iinuma H; Fu LT; Watanabe H
    Jpn Heart J; 2002 Jan; 43(1):55-60. PubMed ID: 12041890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium channel blockers enhance the temporal QT interval variability in the right precordial leads in Brugada syndrome.
    Kanemori T; Shimizu H; Oka K; Furukawa Y; Hiromoto K; Mine T; Masuyama T; Ohyanagi M
    Ann Noninvasive Electrocardiol; 2008 Jan; 13(1):74-80. PubMed ID: 18234009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
    Kanemoto M; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kakugawa H; Kametani R; Inoue N; Sawa A; Matsuzaki M
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):295-303. PubMed ID: 15367827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pilsicainide, a pure sodium channel blocker, on spiral waves during atrial fibrillation: theoretical analysis by numerical simulation.
    Namba T; Ashihara T; Nakazawa K; Ohe T
    J Electrocardiol; 1999 Oct; 32(4):321-34. PubMed ID: 10549908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
    Ueoka A; Morita H; Watanabe A; Morimoto Y; Kawada S; Tachibana M; Miyamoto M; Nakagawa K; Nishii N; Ito H
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia.
    Ueyama T; Shimizu A; Esato M; Yoshiga Y; Sawa A; Suzuki S; Sugi N; Matsuzaki M
    Europace; 2008 Jan; 10(1):86-90. PubMed ID: 18037690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs.
    Itoh H; Shimizu M; Takata S; Mabuchi H; Imoto K
    J Cardiovasc Electrophysiol; 2005 May; 16(5):486-93. PubMed ID: 15877619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electropharmacologic effects of pilsicainide, a pure sodium channel blocker, on the remodeled atrium subjected to chronic rapid pacing.
    Sato T; Mitamura H; Kurita Y; Takeshita A; Shinagawa K; Miyoshi S; Kanki H; Hara M; Ogawa S
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):812-20. PubMed ID: 11707684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
    Doi A; Takagi M; Maeda K; Tatsumi H; Shimeno K; Yoshiyama M
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):688-96. PubMed ID: 20050961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T wave alternans in an in vitro canine tissue model of Brugada syndrome.
    Morita H; Zipes DP; Lopshire J; Morita ST; Wu J
    Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H421-8. PubMed ID: 16648179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brugada syndrome occurring in an identical twin: a case report].
    Sakabe M; Fujiki A; Tsuneda T; Nishida K; Sugao M; Mizumaki K; Inoue H
    J Cardiol; 2002 Sep; 40(3):111-5. PubMed ID: 12325460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia enhances use-dependent sodium channel blockade by pilsicainide, a class IC antiarrhythmic agent.
    Sadanaga T; Ogawa S
    J Am Coll Cardiol; 1994 May; 23(6):1378-81. PubMed ID: 8176096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
    Nagase S; Kusano KF; Morita H; Nishii N; Banba K; Watanabe A; Hiramatsu S; Nakamura K; Sakuragi S; Ohe T
    J Am Coll Cardiol; 2008 Mar; 51(12):1154-61. PubMed ID: 18355652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.